ATE472102T1 - Verfahren zur vorhersage von anomalien des lipidmetabolismus - Google Patents

Verfahren zur vorhersage von anomalien des lipidmetabolismus

Info

Publication number
ATE472102T1
ATE472102T1 AT04808108T AT04808108T ATE472102T1 AT E472102 T1 ATE472102 T1 AT E472102T1 AT 04808108 T AT04808108 T AT 04808108T AT 04808108 T AT04808108 T AT 04808108T AT E472102 T1 ATE472102 T1 AT E472102T1
Authority
AT
Austria
Prior art keywords
compound
predicting
lipidosis
abnomals
lipid metabolism
Prior art date
Application number
AT04808108T
Other languages
English (en)
Inventor
Akira Horinouchi
Ikuo Mori
Mika Murabayashi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE472102T1 publication Critical patent/ATE472102T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04808108T 2003-12-26 2004-12-24 Verfahren zur vorhersage von anomalien des lipidmetabolismus ATE472102T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003434151 2003-12-26
JP2004168849 2004-06-07
PCT/JP2004/019758 WO2005064344A1 (ja) 2003-12-26 2004-12-24 脂質代謝異常症の予測方法

Publications (1)

Publication Number Publication Date
ATE472102T1 true ATE472102T1 (de) 2010-07-15

Family

ID=34742146

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04808108T ATE472102T1 (de) 2003-12-26 2004-12-24 Verfahren zur vorhersage von anomalien des lipidmetabolismus

Country Status (6)

Country Link
US (1) US7399638B2 (de)
EP (1) EP1710585B1 (de)
JP (1) JP4555779B2 (de)
AT (1) ATE472102T1 (de)
DE (1) DE602004027839D1 (de)
WO (1) WO2005064344A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006013465D1 (de) * 2005-07-25 2010-05-20 Basf Se Verfahren zur bereitstellung und analyse einer tierpopulation mit im wesentlichem identischem metabolom
JP5005955B2 (ja) * 2006-05-24 2012-08-22 田辺三菱製薬株式会社 被験物質の脂質代謝異常症誘発可能性を予測する方法
EP2076779A1 (de) * 2006-10-09 2009-07-08 F. Hoffmann-Roche AG Biomarker für mitochondriale toxizität in zusammenhang mit phospholipidose
FI119745B (fi) * 2006-12-05 2009-02-27 Paavo Kinnunen Menetelmä aineen fosfolipidoosia aiheuttavien ominaisuuksien ennustamiseksi
WO2009026153A1 (en) * 2007-08-17 2009-02-26 Metabolon, Inc. Biomarkers for alzheimer's disease and methods using the same
JP5051617B2 (ja) * 2007-12-17 2012-10-17 富士電機株式会社 遠心分離方法及び遠心分離装置
US8313949B2 (en) * 2009-04-16 2012-11-20 Nextcea Inc. Detecting phospholipidosis and diagnosing lysosomal storage disorders
CA2948823C (en) * 2014-05-12 2020-09-22 Quest Diagnostics Investments Incorporated Quantitation of tamoxifen and metabolites thereof by mass spectrometry
JP6051257B2 (ja) * 2015-04-15 2016-12-27 ライオン株式会社 脂質異常症への罹患しやすさを試験する方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100807A (en) 1987-10-19 1992-03-31 Abbott Laboratories Phenylacetylglutamine (pag) analytical test
JPH07104351B2 (ja) 1988-09-29 1995-11-13 株式会社日本抗体研究所 脂質代謝異常検出用キット
JPH11343300A (ja) 1998-03-13 1999-12-14 Tetsuro Fujita 新規ハプテン、それを認識する抗体およびそれらを用いた免疫学的測定法
US6828114B1 (en) * 1998-12-22 2004-12-07 Daiichi Pure Chemicals Co., Ltd. Monoclonal antibody against apolipoprotein A-I
JP2001149082A (ja) * 1999-01-08 2001-06-05 Wakunaga Pharmaceut Co Ltd Ｃｄ３６変異遺伝子並びに脂質代謝異常により引き起こされる疾患の判定法および診断キット
US6306603B1 (en) * 1999-01-08 2001-10-23 Wakunaga Phaemaceutical Co., Ltd. CD36 mutant gene and methods for diagnosing diseases caused by abnormal lipid metabolism and diagnostic kits therefor
JP2001066314A (ja) * 1999-06-23 2001-03-16 E Miller Norman 脂質代謝異常の検出方法及びこれを用いる疾病の検出方法

Also Published As

Publication number Publication date
EP1710585B1 (de) 2010-06-23
EP1710585A4 (de) 2008-02-20
DE602004027839D1 (de) 2010-08-05
JP4555779B2 (ja) 2010-10-06
US7399638B2 (en) 2008-07-15
WO2005064344A1 (ja) 2005-07-14
JPWO2005064344A1 (ja) 2007-07-19
EP1710585A1 (de) 2006-10-11
US20070166829A1 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
Tomat et al. Imaging mobile zinc in biology
ATE412905T1 (de) Diagnoseverfahren für lebersteatose unter verwendung biochemischer marker
ATE420204T1 (de) Verfahren zur detektion von erkrankungen
GB0510943D0 (en) Improved immunoassay methods
ATE472102T1 (de) Verfahren zur vorhersage von anomalien des lipidmetabolismus
EP1532438A4 (de) Oligosaccharid-biomarker für mucopolysaccharidosen und andere verwandte störungen
WO2002093129A3 (en) Methods for analyzing interactions between proteins in live and intact cells
ATE350659T1 (de) Verfahren zur identifizierung von proben eines säugetiers als auch ein kit zur durchführung des verfahrens
Emson et al. A pilot study demonstrating a non-invasive method for the measurement of protein turnover in skin disorders: application to psoriasis
CN101460851B (zh) 与二肽基肽酶有关的疾病状态的诊断和预后
KR101872155B1 (ko) 시스테인 검출용 이광자 형광 프로브 화합물
Ruiz-Hernández et al. Trace element and lipidomic analysis of bottlenose dolphin blubber from the Yucatan coast: Lipid composition relationships
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
Chiaradia et al. In slow pace towards the proteome of equine body fluids
DE60317070D1 (de) Verfahren zur diagnose von multipler sklerose
DE69815394D1 (de) Verfahren zur untersuchung von nierenkrankheiten
Cuervo et al. Einstein-Nathan Shock Center: translating the hallmarks of aging to extend human health span
CN110372738A (zh) 一种定位脂滴检测硫化氢的荧光探针及其制备方法和应用
DE60133997D1 (de) Verfahren zum vorhersagen von preeclampsia und anderen krankheiten
WO2012165926A3 (ko) 항-ａｔｉｃ 자가면역항체를 포함하는 간암 진단 마커 및 이의 항원을 포함하는 간암 진단용 조성물
BR0111975A (pt) Fator, composição, veìculo, ligando, kits de diagnósticos, processos para detectar uma prpsc em uma amostra, e para remover prpsc de material biológico, método para diagnosticar encefalopatias espongiformes humanas transmissìveis e encefalopatias de prìons de animais, e, uso de um fator
JP6017724B1 (ja) 十二指腸液試料の膵液由来成分検出用試料としての適性評価方法
Wragg et al. Synaptic activity regulates the abundance and binding of complexin
WO2004092728A3 (en) Methods of measuring the ability of a test compound to inactivate a biological target in cells of a subject
JP2018145111A (ja) 生体分子検出用蛍光物質

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties